Skip to main content
SpringerLink
Log in

Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Enteric flora constitutes 95% of the cells in the human body. It has been shown that the bacterial content of this flora is affected by diet and changes in nutrition. Considering that urinary tract infections (UTI) are mostly due to ascending infections from the gut flora, the importance of the elements of this flora and their characteristics becomes more evident. The aim of this study was to evaluate the influence of oral Saccharomyces boulardii (S. boulardii) intake on the number of Escherichia coli (E. coli) colonies in the colon. This study was carried out with 14 boys and 10 girls (total of 24 children) aged between 36 and 192 months (mean: 104.3±45.1 months). A commercial capsule or powder containing 5 billion colony-forming units (cfu) of S. boulardii was administered once a day for 5 days. The number of E. coli and yeast colonies was measured in the stool samples of the study group before and after the use of this drug. Before treatment, the mean number of E. coli colonies in g/ml stool was 384,625±445,744. This number decreased significantly to 6,283±20,283 after treatment (p=0.00). S. boulardii was not detected in stool before treatment and the number of colonies increased to 11,047±26,754 in g/ml stool. S. boulardii may be effective in reducing the number of E. coli colonies in stool. The influence of this finding on clinical practice such as prevention of UTI needs to be clarified by further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Stull TL, LiPuma JJ (1991) Epidemiology and natural history of urinary tract infections in children. Med Clin North Am 75:287–297

    Article  CAS  Google Scholar 

  2. Dunne C, O’Mahony L, Murphy L, Thornton G, Morrissey D, O’Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O’Sullivan GC, Shanahan F, Collins JK (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73:386S–392S

    Article  CAS  Google Scholar 

  3. Elmer GW, Surawicz CM, McFarland LV (1996) Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275:870–876

    Article  CAS  Google Scholar 

  4. McFarland LV, Elmer GW (1995) Biotherapeutic agents: past, present and future. Microecology Ther 23:46–73

    Google Scholar 

  5. McFarland LV, Bernasconi P (1993) Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb Ecol Health Dis 6:157–171

    Article  Google Scholar 

  6. Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68:5998–6004

    Article  CAS  Google Scholar 

  7. Kontiokari T, Nuutinen M, Uhari M (2004) Dietary factors affecting susceptibility to urinary tract infection. Pediatr Nephrol 19:378–383

    Article  Google Scholar 

  8. Reid G (2001) Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 73(Suppl):437S–443S

    Article  CAS  Google Scholar 

  9. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:103–108

    Article  CAS  Google Scholar 

  10. Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrob Agents 16:531–536

    Article  CAS  Google Scholar 

  11. Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D (2003) Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71:766–773

    Article  CAS  Google Scholar 

  12. Rodrigues AC, Cara DC, Fretez SH, Cunha FQ, Vieira EC, Nicoli JR, Vieira LQ (2000) Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89:404–414

    Article  CAS  Google Scholar 

  13. Reid G, Burton J (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4:319–324

    Article  Google Scholar 

  14. Howell AB, Vorsa N, Der Marderosian A, Foo LY (1998) Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 339:1085–1086

    Article  CAS  Google Scholar 

  15. Burkhardt O, Kohnlein T, Pletz M, Welte T (2005) Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand J Infect Dis 37:69–71

    Article  CAS  Google Scholar 

  16. Schlager TA, Hendley JO, Bell AL, Whittam TS (2002) Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young children. Infect Immun 70:1225–1229

    Article  CAS  Google Scholar 

  17. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M (2001) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322:1571–1573

    Article  CAS  Google Scholar 

  18. Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 14:11–16

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Nephrology, Celal Bayar University, Manisa, Turkey

    Ipek Akil & Ozge Yilmaz

  2. Department of Microbiology, Celal Bayar University, Manisa, Turkey

    Semra Kurutepe & Kenan Degerli

  3. Department of Pediatric Nephrology, Dokuz Eylül University, Izmir, Turkey

    Salih Kavukcu

  4. 6345 sokak, 50/10, Bostanlý, Karsiyaka, Izmir, Turkey

    Ipek Akil

Authors
  1. Ipek Akil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozge Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Semra Kurutepe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenan Degerli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Salih Kavukcu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ipek Akil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akil, I., Yilmaz, O., Kurutepe, S. et al. Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora. Pediatr Nephrol 21, 807–810 (2006). https://doi.org/10.1007/s00467-006-0088-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-006-0088-4

Keywords

Search

Navigation